[시장보고서]PCA 펌프 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

PCA 펌프 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Patient-controlled Analgesic Pumps Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

상품코드 : 1701650

리서치사 : Persistence Market Research

발행일 : 2025년 04월

페이지 정보 : 영문 250 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,995

￦ 7,261,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295

￦ 10,604,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495

￦ 12,349,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

주요 조사 결과

PCA 펌프 시장 규모 : 7억 800만 달러(2025년)
예상 시장 규모 : 24억 3,510만 달러(2032년)
세계 시장 성장률 : 19.3%(2025-2032년 CAGR)

PCA 펌프 시장 : 보고서 범위

PCA 펌프는 환자가 필요에 따라 조절된 용량의 진통제를 스스로 투여할 수 있도록 하는 의료기기입니다. PCA 펌프는 병원, 외래 환자 시설 및 재택 치료 환경에서 수술 후 통증, 만성 통증 상태 및 완화 치료 관리에 널리 사용되며, 환자의 편안함을 개선하고 의료 서비스 제공자에 대한 의존도를 낮추며 통증 관리의 효율성을 높입니다. 만성질환의 유병률 증가, 효과적인 통증 관리 솔루션에 대한 수요 증가, 수액 펌프 기술의 발전이 시장 성장을 촉진하는 요인으로 작용하고 있습니다.

시장 성장 촉진요인

세계 PCA 펌프 시장은 외과 수술의 증가, 노령 인구의 증가, 관절염 및 암성 통증과 같은 만성 통증 질환 환자의 증가에 의해 주도되고 있습니다. 자동 약물전달 및 실시간 모니터링이 가능한 스마트 수액 시스템과 같은 기술의 발전은 환자의 안전과 치료 효과를 향상시킵니다. 또한, 의료비 증가와 통증 관리에 대한 규제 프레임워크가 시장 확대에 더욱 기여하고 있습니다. 재택 통증 관리 솔루션과 원격의료 서비스로의 전환은 PCA 펌프 제조업체에게 새로운 성장의 길을 열어주고 있습니다.

시장 억제요인

유망한 성장 전망에도 불구하고 PCA 펌프 시장은 높은 장비 비용, 투약 실수 위험, 엄격한 규제 승인 등의 도전에 직면해 있습니다. 환자 오작동이나 펌프 고장으로 인한 과다 또는 과소 투여의 위험은 안전에 대한 우려를 증가시켜 채택률을 제한하고 있습니다. 또한, 신흥 경제권에서는 상환 및 예산 제약으로 인해 첨단 PCA 펌프에 대한 광범위한 접근이 제한되고 있습니다. 이러한 문제를 해결하기 위해서는 지속적인 기기 설계 개선, 의료진에 대한 교육 강화, 보다 합리적인 가격 책정 전략이 필요합니다.

시장 기회

PCA 펌프 시장은 무선 연결, 약물전달의 정확성, 사용자 친화적인 인터페이스의 혁신, AI 기반 분석 및 원격 모니터링 기능의 통합으로 실시간 통증 관리를 강화하고, 재입원을 줄이며, 환자 결과를 개선할 수 있어 큰 성장 기회를 제공합니다. 소아과 및 완화의료 분야에서의 활용 확대, 의료기기 기업과 의료 서비스 제공자 간의 협력 증가는 시장의 잠재력을 더욱 높여주고 있습니다. 또한, 맞춤형 의료 및 환자 중심 치료 모델의 증가 추세는 맞춤형 PCA 펌프 솔루션의 새로운 가능성을 열어줍니다.

이 보고서는 세계 PCA 펌프 시장을 조사하여 성장 촉진요인, 동향, 기회, 과제 등 시장 역학에 대한 상세한 분석을 제공합니다.

소개/주요 조사 결과
시장 규모(금액과 수량) 실적 분석 : 유형별(2019-2024년)
현재와 향후 시장 규모(금액과 수량) 분석과 예측 : 유형별(2025-2032년)
- 전자식
- 기계식
전년비 성장 동향 분석 : 유형별(2019-2024년)
유형 절대적 수익 기회 분석(2025-2032년)

제6장 PCA 펌프 시장 분석 : 용도별(2019-2032년)

소개/주요 조사 결과
시장 규모(금액과 수량) 실적 분석 : 용도별(2019-2024년)
현재와 향후 시장 규모(금액과 수량) 분석과 예측 : 용도별(2025-2032년)
- 당뇨병
- 종양
- 소화기
- 혈액
- 기타 용도
전년비 성장 동향 분석 : 용도별(2019-2024년)
용도 절대적 수익 기회 분석(2025-2032년)

제7장 PCA 펌프 시장 분석 : 최종 용도별(2019-2032년)

소개/주요 조사 결과
시장 규모(금액과 수량) 실적 분석 : 최종 용도별(2019-2024년)
현재와 향후 시장 규모(금액과 수량) 분석과 예측 : 최종 용도별(2025-2032년)
- 병원
- 전문 클리닉
- 외래 수술 센터
- 재택 케어 환경
전년비 성장 동향 분석 : 최종 용도별(2019-2024년)
최종 용도 절대적 수익 기회 분석(2025-2032년)

제8장 PCA 펌프 시장 분석 : 지역별(2019-2032년)

소개
시장 규모(금액과 수량) 실적 분석 : 지역별(2019-2024년)
현재 시장 규모(금액과 수량) 분석과 예측 : 지역별(2025-2032년)
- 북미
- 라틴아메리카
- 유럽
- 아시아태평양
- 중동 및 아프리카
시장 매력 분석 : 지역별

제9장 북미의 PCA 펌프 시장 분석 : 국가별(2019-2032년)

제10장 라틴아메리카의 PCA 펌프 시장 분석 : 국가별(2019-2032년)

제11장 유럽의 PCA 펌프 시장 분석 : 국가별(2019-2032년)

제12장 아시아태평양의 PCA 펌프 시장 분석 : 국가별(2019-2032년)

제13장 중동 및 아프리카의 PCA 펌프 시장 분석 : 국가별(2019-2032년)

제14장 주요 국가의 PCA 펌프 시장 분석

미국
캐나다
브라질
멕시코
독일
영국
프랑스
스페인
이탈리아
러시아
중국
일본
인도
한국
호주
남아프리카공화국
사우디아라비아
아랍에미리트
이스라엘

제15장 시장 구조 분석

경쟁 대시보드
경쟁 벤치마크
주요 기업의 시장 점유율 분석

제16장 경쟁 분석

경쟁 상세
- Smiths Group plc
- Fresenius SE & Co KGaA
- B. Braun Melsungen AG
- Baxter International Inc.
- Becton, Dickinson and Company
- ICU Medical, Inc.
- ACE Medical
- Terumo Corporation
- Pfizer Inc

제17장 가정과 사용되는 두문자어

제18장 조사 방법

ksm

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the worldwide market for patient-controlled analgesic (PCA) pumps. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global patient-controlled analgesic pumps market from 2025 to 2032.

Key Insights:

Patient-Controlled Analgesic Pumps Market Size (2025E): USD 708.0 Million
Projected Market Value (2032F): USD 2,435.1 Million
Global Market Growth Rate (CAGR 2025 to 2032): 19.3%

Patient-Controlled Analgesic Pumps Market - Report Scope:

Patient-controlled analgesic pumps are medical devices that allow patients to self-administer controlled doses of pain medication as needed. These pumps are widely used in hospitals, outpatient facilities, and homecare settings to manage post-surgical pain, chronic pain conditions, and palliative care. PCA pumps help improve patient comfort, reduce dependency on healthcare providers, and enhance pain management efficiency. The increasing prevalence of chronic diseases, rising demand for effective pain management solutions, and advancements in infusion pump technology are driving market growth.

Market Growth Drivers:

The global PCA pumps market is driven by the rising incidence of surgical procedures, the growing elderly population, and increasing cases of chronic pain conditions such as arthritis and cancer-related pain. Technological advancements, including smart infusion systems with automated drug delivery and real-time monitoring, enhance patient safety and treatment efficacy. Additionally, increasing healthcare expenditures, along with supportive regulatory frameworks for pain management, further contribute to market expansion. The shift towards home-based pain management solutions and telehealth services also presents new growth avenues for PCA pump manufacturers.

Market Restraints:

Despite the promising growth outlook, the PCA pumps market faces challenges such as high device costs, risks of medication errors, and stringent regulatory approvals. The risk of overdose or underdose due to patient mismanagement and pump malfunctions raises safety concerns, limiting adoption rates. Additionally, reimbursement constraints and budget limitations in developing economies hinder widespread access to advanced PCA pumps. Addressing these challenges requires continuous improvements in device design, enhanced training for healthcare providers, and more affordable pricing strategies.

Market Opportunities:

The PCA pumps market presents significant growth opportunities through innovations in wireless connectivity, drug delivery precision, and user-friendly interfaces. The integration of AI-powered analytics and remote monitoring capabilities enhances real-time pain management, reducing hospital readmissions and improving patient outcomes. Expanding applications in pediatric and palliative care, along with increasing collaborations between medical device companies and healthcare providers, further boost market potential. Additionally, the growing trend of personalized medicine and patient-centric care models opens new possibilities for customized PCA pump solutions.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the patient-controlled analgesic pumps market globally?
How are technological advancements influencing the competitive landscape of PCA pumps?
What challenges exist in ensuring patient safety and regulatory compliance for PCA pumps?
Who are the key players in the PCA pumps market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global PCA pumps market?

Competitive Intelligence and Business Strategy:

Leading players in the global PCA pumps market, including Becton, Dickinson and Company (BD), Baxter International, Smiths Medical, and ICU Medical, focus on innovation, product safety, and strategic collaborations to strengthen their market presence. These companies invest in R&D to develop advanced PCA pumps with improved accuracy, smart infusion technology, and integrated patient monitoring systems. Strategic partnerships with hospitals, research institutions, and pain management specialists enhance product adoption and market penetration. Additionally, investments in training programs and awareness campaigns help drive demand for PCA pumps in both developed and emerging markets.

Key Companies Profiled:

Smiths Group plc.
Fresenius Kabi Group
Hospira
Micrel Medical Devices,
Ace Medical Co. Ltd.
Terumo Corporation
B.Braun Melsungen AG
Baxter International
Becton Dickinson and Company
ICU Medical

Market Segments Covered in Patient-controlled Analgesic Pumps Market Analysis

By End Use

Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Home Care Settings

By Type

Electronic
Mechanical

By Application

Diabetes
Oncology
Gastroenterology
Hematology
Other Applications

By Region

North America
Latin America
Europe
APAC
MEA

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics
- 3.1.1. Drivers
- 3.1.2. Restraints
- 3.1.3. Opportunity
- 3.1.4. Trends
3.2. Scenario Forecast
- 3.2.1. Demand in Optimistic Scenario
- 3.2.2. Demand in Likely Scenario
- 3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
- 3.5.1. Supply Side Participants and their Roles
  - 3.5.1.1. Producers
  - 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
  - 3.5.1.3. Wholesalers and Distributors
- 3.5.2. Value Added and Value Created at Node in the Supply Chain
- 3.5.3. List of Raw Material Suppliers
- 3.5.4. List of Existing and Potential Buyer's
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
- 3.7.1. Profit Margin Analysis
- 3.7.2. Wholesalers and Distributors
- 3.7.3. Retailers
3.8. PESTLE and Porter's Analysis
3.9. Regulatory Landscape
- 3.9.1. By Key Regions
- 3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics

4. Global Patient-controlled Analgesic Pumps Market Analysis 2019-2032

4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2019-2024
4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2025-2032
- 4.2.1. Y-o-Y Growth Trend Analysis
- 4.2.2. Absolute $ Opportunity Analysis

5. Global Patient-controlled Analgesic Pumps Market Analysis 2019-2032, By Type

5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Type, 2019-2024
5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Type, 2025-2032
- 5.3.1. Electronic
- 5.3.2. Mechanical
5.4. Y-o-Y Growth Trend Analysis By Type, 2019-2024
5.5. Absolute $ Opportunity Analysis By Type, 2025-2032

6. Global Patient-controlled Analgesic Pumps Market Analysis 2019-2032, By Application

6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Application, 2019-2024
6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Application, 2025-2032
- 6.3.1. Diabetes
- 6.3.2. Oncology
- 6.3.3. Gastroenterology
- 6.3.4. Hematology
- 6.3.5. Other Applications
6.4. Y-o-Y Growth Trend Analysis By Application, 2019-2024
6.5. Absolute $ Opportunity Analysis By Application, 2025-2032

7. Global Patient-controlled Analgesic Pumps Market Analysis 2019-2032, By End-use

7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By End-use, 2019-2024
7.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By End-use, 2025-2032
- 7.3.1. Hospitals
- 7.3.2. Specialty Clinics
- 7.3.3. Ambulatory Surgical Centers
- 7.3.4. Home Care Settings
7.4. Y-o-Y Growth Trend Analysis By End-use, 2019-2024
7.5. Absolute $ Opportunity Analysis By End-use, 2025-2032

8. Global Patient-controlled Analgesic Pumps Market Analysis 2019-2032, By Region

8.1. Introduction
8.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2019-2024
8.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2025-2032
- 8.3.1. North America
- 8.3.2. Latin America
- 8.3.3. Europe
- 8.3.4. Asia Pacific
- 8.3.5. MEA
8.4. Market Attractiveness Analysis By Region

9. North America Patient-controlled Analgesic Pumps Market Analysis 2019-2032, By Country

9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2024
9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2025-2032
- 9.2.1. By Country
  - 9.2.1.1. Value (US$ Mn) & Volume (Units)ed States
  - 9.2.1.2. Canada
- 9.2.2. By Type
- 9.2.3. By Application
- 9.2.4. By End-use
9.3. Market Attractiveness Analysis
- 9.3.1. By Country
- 9.3.2. By Type
- 9.3.3. By Application
- 9.3.4. By End-use
9.4. Key Takeaways

10. Latin America Patient-controlled Analgesic Pumps Market Analysis 2019-2032, By Country

10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2024
10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2025-2032
- 10.2.1. By Country
  - 10.2.1.1. Brazil
  - 10.2.1.2. Mexico
  - 10.2.1.3. Rest of Latin America
- 10.2.2. By Type
- 10.2.3. By Application
- 10.2.4. By End-use
10.3. Market Attractiveness Analysis
- 10.3.1. By Country
- 10.3.2. By Type
- 10.3.3. By Application
- 10.3.4. By End-use
10.4. Key Takeaways

11. Europe Patient-controlled Analgesic Pumps Market Analysis 2019-2032, By Country

11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2024
11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2025-2032
- 11.2.1. By Country
  - 11.2.1.1. Germany
  - 11.2.1.2. U.K.
  - 11.2.1.3. France
  - 11.2.1.4. Spain
  - 11.2.1.5. Italy
  - 11.2.1.6. Russia
  - 11.2.1.7. Rest of Europe
- 11.2.2. By Type
- 11.2.3. By Application
- 11.2.4. By End-use
11.3. Market Attractiveness Analysis
- 11.3.1. By Country
- 11.3.2. By Type
- 11.3.3. By Application
- 11.3.4. By End-use
11.4. Key Takeaways

12. Asia Pacific Patient-controlled Analgesic Pumps Market Analysis 2019-2032, By Country

12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2024
12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2025-2032
- 12.2.1. By Country
  - 12.2.1.1. China
  - 12.2.1.2. Japan
  - 12.2.1.3. India
  - 12.2.1.4. South Korea
  - 12.2.1.5. Australia
  - 12.2.1.6. Rest of APAC
- 12.2.2. By Type
- 12.2.3. By Application
- 12.2.4. By End-use
12.3. Market Attractiveness Analysis
- 12.3.1. By Country
- 12.3.2. By Type
- 12.3.3. By Application
- 12.3.4. By End-use
12.4. Key Takeaways

13. MEA Patient-controlled Analgesic Pumps Market Analysis 2019-2032, By Country

13.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2024
13.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2025-2032
- 13.2.1. By Country
  - 13.2.1.1. South Africa
  - 13.2.1.2. Saudi Arabia
  - 13.2.1.3. UAE
  - 13.2.1.4. Israel
  - 13.2.1.5. Rest of MEA
- 13.2.2. By Type
- 13.2.3. By Application
- 13.2.4. By End-use
13.3. Market Attractiveness Analysis
- 13.3.1. By Country
- 13.3.2. By Type
- 13.3.3. By Application
- 13.3.4. By End-use
13.4. Key Takeaways

14. Key Countries Patient-controlled Analgesic Pumps Market Analysis

14.1. Value (US$ Mn) & Volume (Units)ed States
- 14.1.1. Pricing Analysis
- 14.1.2. Market Share Analysis, 2025
  - 14.1.2.1. By Type
  - 14.1.2.2. By Application
  - 14.1.2.3. By End-use
14.2. Canada
- 14.2.1. Pricing Analysis
- 14.2.2. Market Share Analysis, 2025
  - 14.2.2.1. By Type
  - 14.2.2.2. By Application
  - 14.2.2.3. By End-use
14.3. Brazil
- 14.3.1. Pricing Analysis
- 14.3.2. Market Share Analysis, 2025
  - 14.3.2.1. By Type
  - 14.3.2.2. By Application
  - 14.3.2.3. By End-use
14.4. Mexico
- 14.4.1. Pricing Analysis
- 14.4.2. Market Share Analysis, 2025
  - 14.4.2.1. By Type
  - 14.4.2.2. By Application
  - 14.4.2.3. By End-use
14.5. Germany
- 14.5.1. Pricing Analysis
- 14.5.2. Market Share Analysis, 2025
  - 14.5.2.1. By Type
  - 14.5.2.2. By Application
  - 14.5.2.3. By End-use
14.6. U.K.
- 14.6.1. Pricing Analysis
- 14.6.2. Market Share Analysis, 2025
  - 14.6.2.1. By Type
  - 14.6.2.2. By Application
  - 14.6.2.3. By End-use
14.7. France
- 14.7.1. Pricing Analysis
- 14.7.2. Market Share Analysis, 2025
  - 14.7.2.1. By Type
  - 14.7.2.2. By Application
  - 14.7.2.3. By End-use
14.8. Spain
- 14.8.1. Pricing Analysis
- 14.8.2. Market Share Analysis, 2025
  - 14.8.2.1. By Type
  - 14.8.2.2. By Application
  - 14.8.2.3. By End-use
14.9. Italy
- 14.9.1. Pricing Analysis
- 14.9.2. Market Share Analysis, 2025
  - 14.9.2.1. By Type
  - 14.9.2.2. By Application
  - 14.9.2.3. By End-use
14.10. Russia
- 14.10.1. Pricing Analysis
- 14.10.2. Market Share Analysis, 2025
  - 14.10.2.1. By Type
  - 14.10.2.2. By Application
  - 14.10.2.3. By End-use
14.11. China
- 14.11.1. Pricing Analysis
- 14.11.2. Market Share Analysis, 2025
  - 14.11.2.1. By Type
  - 14.11.2.2. By Application
  - 14.11.2.3. By End-use
14.12. Japan
- 14.12.1. Pricing Analysis
- 14.12.2. Market Share Analysis, 2025
  - 14.12.2.1. By Type
  - 14.12.2.2. By Application
  - 14.12.2.3. By End-use
14.13. India
- 14.13.1. Pricing Analysis
- 14.13.2. Market Share Analysis, 2025
  - 14.13.2.1. By Type
  - 14.13.2.2. By Application
  - 14.13.2.3. By End-use
14.14. South Korea
- 14.14.1. Pricing Analysis
- 14.14.2. Market Share Analysis, 2025
  - 14.14.2.1. By Type
  - 14.14.2.2. By Application
  - 14.14.2.3. By End-use
14.15. Australia
- 14.15.1. Pricing Analysis
- 14.15.2. Market Share Analysis, 2025
  - 14.15.2.1. By Type
  - 14.15.2.2. By Application
  - 14.15.2.3. By End-use
14.16. South Africa
- 14.16.1. Pricing Analysis
- 14.16.2. Market Share Analysis, 2025
  - 14.16.2.1. By Type
  - 14.16.2.2. By Application
  - 14.16.2.3. By End-use
14.17. Saudi Arabia
- 14.17.1. Pricing Analysis
- 14.17.2. Market Share Analysis, 2025
  - 14.17.2.1. By Type
  - 14.17.2.2. By Application
  - 14.17.2.3. By End-use
14.18. UAE
- 14.18.1. Pricing Analysis
- 14.18.2. Market Share Analysis, 2025
  - 14.18.2.1. By Type
  - 14.18.2.2. By Application
  - 14.18.2.3. By End-use
14.19. Israel
- 14.19.1. Pricing Analysis
- 14.19.2. Market Share Analysis, 2025
  - 14.19.2.1. By Type
  - 14.19.2.2. By Application
  - 14.19.2.3. By End-use

15. Market Structure Analysis

15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
- 15.3.1. By Regional
- 15.3.2. By Type
- 15.3.3. By Application
- 15.3.4. By End-use

16. Competition Analysis

16.1. Competition Deep Dive
- 16.1.1. Smiths Group plc
  - 16.1.1.1. Overview
  - 16.1.1.2. Product Portfolio
  - 16.1.1.3. Profitability by Market Segments
  - 16.1.1.4. Sales Footprint
  - 16.1.1.5. Strategy Overview
    - 16.1.1.5.1. Marketing Strategy
    - 16.1.1.5.2. Product Strategy
    - 16.1.1.5.3. Channel Strategy
- 16.1.2. Fresenius SE & Co KGaA
  - 16.1.2.1. Overview
  - 16.1.2.2. Product Portfolio
  - 16.1.2.3. Profitability by Market Segments
  - 16.1.2.4. Sales Footprint
  - 16.1.2.5. Strategy Overview
    - 16.1.2.5.1. Marketing Strategy
    - 16.1.2.5.2. Product Strategy
    - 16.1.2.5.3. Channel Strategy
- 16.1.3. B. Braun Melsungen AG
  - 16.1.3.1. Overview
  - 16.1.3.2. Product Portfolio
  - 16.1.3.3. Profitability by Market Segments
  - 16.1.3.4. Sales Footprint
  - 16.1.3.5. Strategy Overview
    - 16.1.3.5.1. Marketing Strategy
    - 16.1.3.5.2. Product Strategy
    - 16.1.3.5.3. Channel Strategy
- 16.1.4. Baxter International Inc.
  - 16.1.4.1. Overview
  - 16.1.4.2. Product Portfolio
  - 16.1.4.3. Profitability by Market Segments
  - 16.1.4.4. Sales Footprint
  - 16.1.4.5. Strategy Overview
    - 16.1.4.5.1. Marketing Strategy
    - 16.1.4.5.2. Product Strategy
    - 16.1.4.5.3. Channel Strategy
- 16.1.5. Becton, Dickinson and Company
  - 16.1.5.1. Overview
  - 16.1.5.2. Product Portfolio
  - 16.1.5.3. Profitability by Market Segments
  - 16.1.5.4. Sales Footprint
  - 16.1.5.5. Strategy Overview
    - 16.1.5.5.1. Marketing Strategy
    - 16.1.5.5.2. Product Strategy
    - 16.1.5.5.3. Channel Strategy
- 16.1.6. ICU Medical, Inc.
  - 16.1.6.1. Overview
  - 16.1.6.2. Product Portfolio
  - 16.1.6.3. Profitability by Market Segments
  - 16.1.6.4. Sales Footprint
  - 16.1.6.5. Strategy Overview
    - 16.1.6.5.1. Marketing Strategy
    - 16.1.6.5.2. Product Strategy
    - 16.1.6.5.3. Channel Strategy
- 16.1.7. ACE Medical
  - 16.1.7.1. Overview
  - 16.1.7.2. Product Portfolio
  - 16.1.7.3. Profitability by Market Segments
  - 16.1.7.4. Sales Footprint
  - 16.1.7.5. Strategy Overview
    - 16.1.7.5.1. Marketing Strategy
    - 16.1.7.5.2. Product Strategy
    - 16.1.7.5.3. Channel Strategy
- 16.1.8. Terumo Corporation
  - 16.1.8.1. Overview
  - 16.1.8.2. Product Portfolio
  - 16.1.8.3. Profitability by Market Segments
  - 16.1.8.4. Sales Footprint
  - 16.1.8.5. Strategy Overview
    - 16.1.8.5.1. Marketing Strategy
    - 16.1.8.5.2. Product Strategy
    - 16.1.8.5.3. Channel Strategy
- 16.1.9. Pfizer Inc
  - 16.1.9.1. Overview
  - 16.1.9.2. Product Portfolio
  - 16.1.9.3. Profitability by Market Segments
  - 16.1.9.4. Sales Footprint
  - 16.1.9.5. Strategy Overview
    - 16.1.9.5.1. Marketing Strategy
    - 16.1.9.5.2. Product Strategy
    - 16.1.9.5.3. Channel Strategy